A pilot clinical study of VAL-413 (oral irinotecan HCl) in patients with recurrent pediatric solid tumors.

被引：0
|
作者：
Brown, Dennis
Bacha, Jeffrey A.
Geller, James I.
Thompson, Patrick A.
Oesterheld, Javier E.
Kanekal, Sarath
Leggas, Markos
Lopez, Lorena
Sankar, Neil
Yam, Noymi
Wagner, Lars M.
机构：
[1] Edison Oncol Holding Corp, Menlo Pk, CA USA
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
[3] Univ N Carolina, North Carolina Childrens Hosp, Chapel Hill, NC USA
[4] Levine Childrens Hosp, Carolinas Med Ctr, Charlotte, NC USA
[5] St Jude Childrens Res Hosp, Memphis, TN USA
[6] Cincinnati Childrens Hosp, Cincinnati, OH USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS10063
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Phase I and translational study of capecitabine, cisplatin, and irinotecan in patients with solid tumors.
    Verschraegen, CF
    Lee, FC
    Rabinowitz, I
    Mangalik, A
    Jennings, C
    Maestas, A
    Shen, Z
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 155S - 155S
  • [12] Phase I study of talazoparib and irinotecan in children and young adults with recurrent/refractory solid tumors.
    Federico, Sara Michele
    Stewart, Elizabeth
    Coleman, Jamie L.
    Bishop, Michael William
    Santana, Victor M.
    Lam, Catherine
    Hawkins, Dana
    Wu, Jianrong
    Mao, Shenghua
    Goshorn, David Ross
    Papp, Alberto S.
    Dyer, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [13] Phase 1 Study of Regorafenib in Combination With Vincristine and Irinotecan in Pediatric Patients With Recurrent or Refractory Solid Tumors
    Casanova, M.
    Bautista, F.
    Campbell-Hewson, Q.
    Makin, G.
    Marshall, L. V.
    Verschuur, A.
    Canete Nieto, A.
    Corradini, N.
    Ploeger, B.
    Mueller, U.
    Zebger-Gong, H.
    Chung, J.
    Geoerger, B.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S20 - S20
  • [14] Effect of gefitinib on the systemic disposition of intravenous irinotecan (IRN) in pediatric patients with refractory solid tumors.
    Iacono, LC
    Furman, WL
    Crews, KR
    Panetta, JC
    Freeman, BB
    Daw, NC
    Stewart, CF
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 129S - 129S
  • [15] Pharmacokinetic and pharmacodynamic investigation of irinotecan hydrochloride in pediatric patients with recurrent or progressive solid tumors
    Kimura, T.
    Kashiwase, S.
    Makimoto, A.
    Kumagai, M.
    Taga, T.
    Ishida, Y.
    Ida, K.
    Nagatoshi, Y.
    Mugishima, H.
    Kaneko, M.
    Barrett, J. S.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (05) : 327 - 334
  • [16] Phase I study of irinotecan in pediatric patients with malignant solid tumors
    Mugishima, H
    Matsunaga, T
    Yagi, K
    Asami, K
    Mimaya, J
    Suita, S
    Kishimoto, T
    Sawada, T
    Tsuchida, Y
    Kaneko, M
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (02) : 94 - 100
  • [17] Phase I study of single-agent perifosine for recurrent pediatric solid tumors.
    Becher, O. J.
    Trippett, T. M.
    Kolesar, J.
    Gilheeney, S.
    Jiang, Z.
    Khakoo, Y.
    Lyden, D.
    Sima, C.
    Holland, E. C.
    Dunkel, I. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [18] A phase 1 study of oral navelbine in patients with advanced solid tumors.
    Rajdev, L
    Dai, Q
    Mani, S
    Goldberg, G
    Baker, C
    Hoschander, S
    Sparano, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6137S - 6137S
  • [19] Phase 1 Study of Oxaliplatin and Irinotecan in Pediatric Patients With Refractory Solid Tumors
    McGregor, Lisa M.
    Spunt, Sheri L.
    Furman, Wayne L.
    Stewart, Clinton F.
    Schaiquevich, Paula
    Krailo, Mark D.
    Speights, RoseAnne
    Ivy, Percy
    Adamson, Peter C.
    Blaney, Susan M.
    CANCER, 2009, 115 (08) : 1765 - 1775
  • [20] Regorafenib plus Vincristine and Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors: An Innovative Therapy for Children with Cancer Study
    Casanova, Michela
    Bautista, Francisco
    Campbell-Hewson, Quentin
    Makin, Guy
    Marshall, Lynley V.
    Verschuur, Arnauld C.
    Canete Nieto, Adela
    Corradini, Nadege
    Ploeger, Bart A.
    Brennan, Barbara J.
    Mueller, Udo
    Zebger-Gong, Hong
    Chung, John W.
    Geoerger, Birgit
    CLINICAL CANCER RESEARCH, 2023, 29 (21) : 4341 - 4351
12345